The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 18, 2018
Filed:
Aug. 16, 2016
Applicant:
Aston University, Birmingham, GB;
Inventors:
Michael J. Tisdale, Claverdon, GB;
Steven Russell, Wedensbury, GB;
Assignee:
Aston University, Birmingham, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/00 (2006.01); A61K 38/28 (2006.01); C07K 14/47 (2006.01); A61K 9/00 (2006.01); A61K 31/137 (2006.01); A61K 38/17 (2006.01); A61K 38/26 (2006.01); A61K 31/138 (2006.01); A61K 45/06 (2006.01); A23L 33/17 (2016.01); A61K 47/60 (2017.01); A61K 47/61 (2017.01);
U.S. Cl.
CPC ...
C07K 14/473 (2013.01); A23L 33/17 (2016.08); A61K 9/0014 (2013.01); A61K 9/0043 (2013.01); A61K 9/0053 (2013.01); A61K 31/137 (2013.01); A61K 31/138 (2013.01); A61K 38/17 (2013.01); A61K 38/1709 (2013.01); A61K 38/1741 (2013.01); A61K 38/26 (2013.01); A61K 38/28 (2013.01); A61K 45/06 (2013.01); A61K 47/60 (2017.08); A61K 47/61 (2017.08);
Abstract
The invention provides formulations and methods for ameliorating symptoms associated with metabolic disorders, such as cachexia, hypoglycemia, obesity, diabetes, and the like by administering Zn-α-glycoproteins or a functional fragment thereof, alone or in combination with additional agents, such as β adrenergin receptor agonists, β adrenergin receptor antagonists, and/or glycemic control agents.